AlphaStocks
6.0
Consider Buy

Organon & Co. (OGN)

Health Care / Pharmaceuticals

S&P SmallCap 600

$13.41

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#254out of 1125 in Health Care

Is Organon & Co. a Good Investment in 2026?

Organon & Co. (OGN) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates Organon & Co. as Strong (Top half (rank 36%)). However, the Lynch model rates it Caution. Organon & Co. ranks #254 out of 1125 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E18.7ROE15.4Market Cap4BDiv Yield2.5

Valuation

Trades at 19x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

60% above fair value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Strong

Top half (rank 36%)

Frequently Asked Questions

Is Organon & Co. (OGN) a good investment?
Based on AlphaStocks' composite analysis, Organon & Co. (OGN) scores 6.0 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trades at 19x earnings — near sector median of 25x.
What is Organon & Co.'s Piotroski F-Score?
Organon & Co.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is OGN overvalued or undervalued?
A precise fair value estimate is not available for OGN. Trades at 19x earnings — near sector median of 25x.
How does OGN compare to other Health Care stocks?
Organon & Co. ranks #254 out of 1125 stocks in the Health Care sector, placing it in the top 23% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about OGN?
AlphaStocks evaluates OGN using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.0/10.

Similar Stocks

BFAMAZNKLIC

Compare OGN with

OGN vs BFAMOGN vs AZNOGN vs KLIC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer